- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
Patent holdings for IPC class C07K 16/08
Total number of patents in this class: 1326
10-year publication summary
67
|
80
|
87
|
111
|
101
|
106
|
127
|
116
|
115
|
33
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Regeneron Pharmaceuticals, Inc. | 3650 |
22 |
Novartis AG | 11238 |
21 |
Deutsches Krebsforschungszentrum | 417 |
19 |
Genentech, Inc. | 3742 |
18 |
The Regents of the University of California | 18943 |
16 |
Duke University | 2872 |
16 |
City of Hope | 943 |
16 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
14 |
Xiamen University | 488 |
14 |
Humabs Biomed SA | 115 |
13 |
Yang Sheng Tang Company Limited | 56 |
13 |
Institute for Research in Biomedicine | 95 |
12 |
Pontificia Universidad Catolica de Chile | 268 |
12 |
VIR Biotechnology, Inc. | 114 |
12 |
Xencor, Inc. | 403 |
12 |
The Rockefeller University | 562 |
11 |
The University of North Carolina at Chapel Hill | 1928 |
11 |
Vanderbilt University | 1731 |
11 |
Icahn School of Medicine at Mount Sinai | 859 |
10 |
F. Hoffmann-La Roche AG | 7958 |
9 |
Other owners | 1044 |